Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 15, 2024. (Total: 232521Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 11 (of 11 Records)

Query Trace: Lung Neoplasms and MAX[original query]
Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers.
European journal of clinical pharmacology 2012 Dec 68 (12): 1677-80.
Ruan Can-Jun, Liu Dong-Yang, Jiang Ji, Hu P
Landscape of the relationship between type 2 diabetes and coronary heart disease through an integrated gene network analysis.
Gene 2014 Apr 539 (1): 30-6.
Dong Changzheng, Tang Linlin, Liu Zhifang, Bu Shizhong, Liu Qiong, Wang Qinwen, Mai Yifeng, Wang Dao Wen, Duan Shiw
Pharmacokinetic properties of two erlotinib 150 mg formulations with a genetic effect evaluation in healthy Korean subjects.
Clinical drug investigation 2015 Jan 35 (1): 31-43.
Choi Hyun-Gyu, Jeon Ji-Young, Im Yong-Jin, Kim Yunjeong, Song Eun-Kee, Seo Young-Hwan, Cho Seok-Je, Kim Min-G
Ultrasonography-Guided Core Biopsy of Supraclavicular Lymph Nodes for Diagnosis of Metastasis and Identification of Epidermal Growth Factor Receptor (EGFR) Mutation in Advanced Lung Cancer.
Medicine 2015 Jul 94 (29): e1209.
Choe Jooae, Kim Mi Young, Baek Jung Hwan, Choi Chang-Min, Kim Hwa Ju
Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.
Cancer research 2017 9 77 (22): 6119-6130.
Sivakumar Smruthy, Lucas F Anthony San, McDowell Tina L, Lang Wenhua, Xu Li, Fujimoto Junya, Zhang Jianjun, Futreal P Andrew, Fukuoka Junya, Yatabe Yasushi, Dubinett Steven M, Spira Avrum E, Fowler Jerry, Hawk Ernest T, Wistuba Ignacio I, Scheet Paul, Kadara Hum
KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb .
Sullivan I, Salazar J, Arqueros C, Andrés M, Sebio A, Majem M, Szafranska J, Martínez E, Páez D, López-Pousa A, Baiget M, Barnadas
Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India.
South Asian journal of cancer 2018 2 6 (4): 171-175.
Singh Randeep, Rohtagi Nite
Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity.
Oncology letters 2019 8 18 (2): 2118-2124.
Tang Yong, Liu Xianling, Ou Zhu'An, He Zhe, Zhu Qihang, Wang Ye, Yang Mei, Ye Junyi, Han-Zhang Han, Qiao Guib
Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer.
Disease markers 2019 2019 3837687.
Kang Jingjing, Luo Yang, Wang Di, Men Yu, Wang Jianyang, Che Yi-Qun, Hui Zhougua
Germline mutation analyses of malignant ground glass opacity nodules in non-smoking lung adenocarcinoma patients.
PeerJ 2021 9 e12048.
Mao Wenjun, Chen Ruo, Lu Rongguo, Wang Shengfei, Song Huizhu, You Dan, Liu Feng, He Yijun, Zheng Mingfe
Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer.
Cancer letters 2023 12 582 216569.
Yufan Yang, Jianyang Wang, Jingbo Wang, Xiaotian Zhao, Tao Zhang, Yin Yang, Jiaohui Pang, Qiuxiang Ou, Linfang Wu, Xin Xu, Kunpeng Xu, Jingjing Zhao, Na Bai, Peng Yang, Sha Wang, Luhua Wang, Nan
TOP